1. Home
  2. PRPL vs XBIT Comparison

PRPL vs XBIT Comparison

Compare PRPL & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Purple Innovation Inc.

PRPL

Purple Innovation Inc.

HOLD

Current Price

$0.40

Market Cap

76.9M

ML Signal

HOLD

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.43

Market Cap

74.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRPL
XBIT
Founded
2010
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.9M
74.4M
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
PRPL
XBIT
Price
$0.40
$2.43
Analyst Decision
Hold
Analyst Count
2
0
Target Price
$0.65
N/A
AVG Volume (30 Days)
411.4K
20.1K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
152.75
N/A
EPS
N/A
N/A
Revenue
$468,725,000.00
N/A
Revenue This Year
$8.50
N/A
Revenue Next Year
$6.68
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.39
$2.09
52 Week High
$1.26
$3.61

Technical Indicators

Market Signals
Indicator
PRPL
XBIT
Relative Strength Index (RSI) 31.65 48.22
Support Level $0.39 $2.35
Resistance Level $0.73 $2.49
Average True Range (ATR) 0.03 0.06
MACD 0.00 -0.01
Stochastic Oscillator 6.78 42.86

Price Performance

Historical Comparison
PRPL
XBIT

About PRPL Purple Innovation Inc.

Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Share on Social Networks: